Shelley B. Thunen serves as Executive at INTRALASE CORP, where they oversee executive responsibilities. Since joining the company, Shelley B. Thunen has executed 122 insider transactions totaling $7.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 31, 2024 involved receiving (via award) 36,021 shares valued at $0.
Shelley B. Thunen currently holds 36,021 shares of INTRALASE CORP (ILSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shelley B. Thunen has been a net seller of ILSE stock. They have purchased $0 and sold $7.8M worth of shares.
Shelley B. Thunen's most recent insider trade was on Aug 31, 2024, when they sold 36,021 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.34 |
| Discretionary |
| May 1, 2024 | RXST | $20.2K | Sale | 380 | $53.04 | Planned |
| May 1, 2024 | RXST | $506.8K | Sale | 9,620 | $52.68 | Planned |
| May 1, 2024 | RXST | $159.9K | Option Exercise | 10,247 | $15.60 | Planned |
| Apr 1, 2024 | RXST | $441.2K | Sale | 8,857 | $49.81 | Planned |
| Apr 1, 2024 | RXST | $10.1K | Sale | 200 | $50.37 | Planned |
| Apr 1, 2024 | RXST | $28.0K | Sale | 543 | $51.50 | Planned |
| Apr 1, 2024 | RXST | $40.2K | Sale | 800 | $50.27 | Planned |
| Apr 1, 2024 | RXST | $445.2K | Sale | 8,938 | $49.81 | Planned |
| Apr 1, 2024 | RXST | $33.3K | Sale | 662 | $50.24 | Planned |
| Mar 1, 2024 | RXST | $141.0K | Sale | 2,473 | $57.03 | Planned |
| Mar 1, 2024 | RXST | $358.6K | Sale | 6,361 | $56.38 | Planned |
| Mar 1, 2024 | RXST | $64.1K | Sale | 1,166 | $54.95 | Planned |
| Mar 1, 2024 | RXST | $156.0K | Option Exercise | 10,000 | $15.60 | Planned |
| Feb 6, 2024 | RXST | $237.3K | Option Exercise | 15,875 | $14.95 | Discretionary |
| Feb 6, 2024 | RXST | $753.6K | Sale | 15,875 | $47.47 | Discretionary |
| Feb 5, 2024 | RXST | $429.1K | Sale | 9,125 | $47.02 | Discretionary |
| Feb 5, 2024 | RXST | $29.9K | Option Exercise | 6,900 | $4.34 | Discretionary |
| Feb 5, 2024 | RXST | $136.4K | Option Exercise | 9,125 | $14.95 | Discretionary |
| Jan 26, 2024 | RXST | $479.1K | Option Exercise | 31,772 | $15.08 | Discretionary |
| Jan 26, 2024 | RXST | $1.5M | Sale | 31,772 | $47.11 | Discretionary |
| Jan 26, 2024 | RXST | $19.5K | Option Exercise | 4,500 | $4.34 | Discretionary |
| Jan 2, 2024 | RXST | $156.0K | Option Exercise | 10,000 | $15.60 | Planned |
| Jan 2, 2024 | RXST | $175.2K | Sale | 4,519 | $38.77 | Planned |
| Jan 2, 2024 | RXST | $217.2K | Sale | 5,481 | $39.63 | Planned |
| Dec 15, 2023 | RXST | $787.0K | Sale | 20,000 | $39.35 | Planned |
| Dec 15, 2023 | RXST | $393.1K | Sale | 10,000 | $39.31 | Planned |
| Dec 15, 2023 | RXST | $393.2K | Sale | 10,000 | $39.32 | Planned |
| Dec 15, 2023 | RXST | $312.0K | Option Exercise | 20,000 | $15.60 | Planned |